Valentin, J P <br/><br/>
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.  [electronic resource] 

 -  American journal of hypertension  Sep 1997 
 - 1058-63 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0895-7061 
<br/><br/><label>Standard No.: </label>10.1016/s0895-7061(97)00276-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Blood Pressure--drug effects<br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Capillary Permeability--drug effects<br/>Enalapril--pharmacology<br/>Fatty Acids, Unsaturated<br/>Hematocrit<br/>Hydrazines--pharmacology<br/>Losartan--pharmacology<br/>Male<br/>Microcirculation--drug effects<br/>Plasma Volume--drug effects<br/>Prostaglandins--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cell Surface--physiology<br/>Receptors, Thromboxane--physiology<br/>Serum Albumin--metabolism<br/>Vasoconstrictor Agents--pharmacology